We performed both in vitro and in vivo experiments to investigate how FGFR2+ fibrocytes were differentiated into CAFs using FGFR2+ fibrocytes isolated from peripheral blood of ESCC patients. This evidence concerns the gene FGFR2 and esophageal squamous cell carcinoma.